O015/#502 Molecular stratification of ovarian clear cell carcinoma predicts clinical outcomes

S. Gordhandas, B. Manning-Geist, Anjelica Hodgson, Qin C Zhou, A. Iasonos, D. Chi, A. Momeni-Boroujeni, N. Abu-Rustum, Mario Leitão, K. L. Long Roche, Y. Sonoda, C. Aghajanian, K. Alektiar, R. Grisham, O. Zivanovic, L. Ellenson, B. Weigelt
{"title":"O015/#502 Molecular stratification of ovarian clear cell carcinoma predicts clinical outcomes","authors":"S. Gordhandas, B. Manning-Geist, Anjelica Hodgson, Qin C Zhou, A. Iasonos, D. Chi, A. Momeni-Boroujeni, N. Abu-Rustum, Mario Leitão, K. L. Long Roche, Y. Sonoda, C. Aghajanian, K. Alektiar, R. Grisham, O. Zivanovic, L. Ellenson, B. Weigelt","doi":"10.1136/ijgc-2022-igcs.17","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":348678,"journal":{"name":"Oral Abstracts (Regular and Late-Breaking Submission)","volume":"19 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Abstracts (Regular and Late-Breaking Submission)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2022-igcs.17","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
卵巢透明细胞癌的分子分层预测临床结果
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
O014/#415 Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: an NRG oncology study LB002/#1545 Late-breaking abstract presentation: comparative effectiveness of HIPEC following interval cytoreductive surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy: multicenter, prospective, cohort study (KGOG 3042) O012/#352 Atezolizumab and bevacizumab in recurrent endometrial cancer: a phase II, multi institutional trial O006/#1066 Randomized trial of pelvic radiation with and without concurrent cisplatin in patients with a pelvic only recurrence of endometrial cancer O007/#456 Post-hoc analysis of objective response rate by mismatch repair protein dimer loss/mutation status in patients with mismatch repair deficient endometrial cancer treated with dostarlimab
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1